top of page

Gift from the IPF Foundation to support FAKnostics' IPF journey to clinical trials!

  • Feb 17
  • 1 min read

FAKnostics is honored to announce that the IPF Foundation has made a generous gift to support us as we advance our promising idiopathic pulmonary fibrosis (IPF) therapeutic toward clinical trials.


We are deeply grateful to the IPF Foundation, as well as to our partners, team, and the broader IPF community, for helping make this important milestone possible.


Want to learn more about the IPF Foundation? Visit www.ipffoundation.org. 


Smiling nurse and elderly woman in conversation. IPF Foundation text promotes preclinical studies. Blue tones dominate. www.faknostics.com visible.

 
 

Discover FAKnostics products in pipeline

Stay in the know

Never miss an update on FAKnostics successes.

Thanks for submitting!

We are developing next generation drugs that inhibit tumor growth through targeting protein-protein interactions on the FAK scaffold.

FAKnostics LLC

850 N. 5th Street

Suite #545
Phoenix, AZ 85004 

© 2023 by FAKnostics. Privacy Policy.

  • LinkedIn
bottom of page